The management of type 2 diabetes mellitus FOCUS on quality

被引:2
|
作者
Miser, William F. [1 ]
机构
[1] Ohio State Univ, Coll Med & Publ Hlth, Dept Family Med, Columbus, OH 43201 USA
来源
PRIMARY CARE | 2007年 / 34卷 / 01期
关键词
D O I
10.1016/j.pop.2007.01.001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Diabetes mellitus (DM) is a group of metabolic disorders associated with abnormalities in carbohydrate, lipid, and protein metabolism [1-3]. The common feature of DM-hyperglycemia-is caused by defects in insulin secretion, insulin action (resistance), or both, with resulting long-term damage to various organs and diminished quality of life. The upper limit of normal fasting plasma glucose is 109 mg/dL. Although this number is somewhat arbitrary, values above this level are associated with a progressively greater risk of developing the many micro- and macrovascular complications associated with DM. The American Diabetes Association (ADA) has established three ways in which one can diagnose a patient as having DM (Box 1) [2,4]. Hemoglobin Alc (HbA1c) levels correlate with the average level of blood glucose over the previous I to 3 months [4-6]. Correlation is higher for glucose levels at lunch time than earlier in the day and is higher for glucose levels in the most recent 30 days than from the prior 31 to 120 days [7]. Although useful in monitoring the degree of glycemic control, the ADA currently does not recommend Its use for diagnostic purposes because there is a lack of its standardization among laboratories. Some investigators advocate its use in diagnosing DM, however, especially when performed in centers in which the test has been standardized [4].
引用
收藏
页码:1 / +
页数:39
相关论文
共 50 条
  • [1] Mammalian models of diabetes mellitus, with a focus on type 2 diabetes mellitus
    Lutz, Thomas A. A.
    NATURE REVIEWS ENDOCRINOLOGY, 2023, 19 (06) : 350 - 360
  • [2] Mammalian models of diabetes mellitus, with a focus on type 2 diabetes mellitus
    Thomas A. Lutz
    Nature Reviews Endocrinology, 2023, 19 : 350 - 360
  • [3] Quality assessment of clinical practice guidelines for management of type 2 diabetes mellitus Assessment of type 2 diabetes mellitus guidelines
    Koc, E. Meltem
    Aksoy, Hilal
    Baser, Duygu Ayhan
    Artantas, Aylin Baydar
    Kahveci, Rabia
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 152 : 119 - 124
  • [4] THE QUALITY OF SELF-MANAGEMENT OF TYPE 2 DIABETES MELLITUS BY PATIENTS
    Bekbergenova, Z.
    Akhmetova, D.
    Zholdybay, A.
    Bazarbay, A.
    Issa, A.
    Kozhabayeva, N.
    Nurzhan, A.
    Azimberdi, B.
    Mergeneva, A.
    Salimova, A.
    Kalina, V
    VALUE IN HEALTH, 2020, 23 : S514 - S514
  • [5] Improving Management of Type 2 Diabetes Mellitus in Hospitalized Adults: A Quality Initiative
    Wahlberg, Elizabeth A.
    Muthukrishnan, Preetika
    Burnett, Maria
    Barrett, Kaitlyn, V
    Gilbert, Matthew
    Repp, Allen B.
    JOURNAL FOR HEALTHCARE QUALITY, 2021, 43 (02) : E20 - E25
  • [6] MANAGEMENT OF TYPE 2 DIABETES MELLITUS IN GREENLAND, 2008: EXAMINING THE QUALITY AND ORGANIZATION OF DIABETES CARE
    Pedersen, Michael Lynge
    INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2009, 68 (02) : 123 - 132
  • [7] Specializing Architectures for the Type 2 Diabetes Mellitus Care Use Cases with a Focus on Process Management
    Uribe, Gustavo A.
    Blobel, Bernd
    Lopez, Diego M.
    Ruiz, Alonso A.
    PROCEEDINGS OF THE 12TH INTERNATIONAL CONFERENCE ON WEARABLE MICRO AND NANO TECHNOLOGIES FOR PERSONALIZED HEALTH (PHEALTH 2015), 2015, 211 : 132 - 142
  • [8] Glycemic Management of Type 2 Diabetes Mellitus
    Drury, Paul L.
    Cundy, Tim
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02): : 182 - 182
  • [9] Review of management of type 2 diabetes mellitus
    Yap, WS
    Peterson, GM
    Vial, JH
    Randall, CTC
    Greenaway, TM
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1998, 23 (06) : 457 - 465
  • [10] Albuminuria and Management of Type 2 Diabetes Mellitus
    Ganji, Mohammad Reza
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2013, 7 (04) : 245 - 248